Sinopharm proposes re-electing Jin Bin as chairman for seventh board term

• Sinopharm set an extraordinary general meeting for Sept. 15, 2026 to vote on re-electing directors for its seventh board term.
• Executive director slate includes President Lian Wanyong, a pharmacist with prior senior roles at parent CNPGC and listed unit Shanghai Shyndec.
• Deputy party secretary Yang Binghua is also nominated as executive director; he previously held senior roles at SASAC and CNPGC.
• Chairman Jin Bin is up for re-election as non-executive director; he is CNPGC deputy general manager, chief compliance officer, former CNPGC office director.
• Independent director candidates include CEIBS strategy professor Chen Weiru, former Alibaba Cainiao chief strategy officer, plus finance and legal specialists.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12308019), on August 31, 2026, and is solely responsible for the information contained therein.